Advertisement

Pain Management

Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study

Apr 18, 2019

(Reuters) - A lower dose of non-opioid painkiller developed by Pfizer Inc and Eli Lilly and Co failed to meet main goals in a late-stage study in patients with moderate-to-severe osteoa...

Curbing Long-term Opioid Use: The Case for Early Physical Therapy

Apr 18, 2019

Early physical therapy (PT) may help reduce the risk of long-term opioid use by serving as an alternative or adjunct to short-term opioid use for patients with various types of musculoskeletal pain. P...

Sixty People Charged in Massive Opioid Painkiller Investigation

Apr 18, 2019

THURSDAY, April 18, 2019 (HealthDay News) -- Fifty-three medical professionals, including 31 doctors, are among the 60 people charged by U.S. authorities for their alleged involvement in the illegal p...

Dozens of doctors in Appalachia charged in opioid fraud bust

Apr 17, 2019

By Gabriella Borter (Reuters) - Dozens of medical professionals in Appalachia, a region hard-hit by the U.S. opioid crisis, have been charged with writing hundreds of thou...

Barriers to Opioid Use Disorder Treatment Should Be Addressed

Apr 16, 2019

TUESDAY, April 16, 2019 (HealthDay News) -- Barriers to accessing treatment for opioid use disorder (OUD) need to be addressed to help curb the epidemic, according to a report published by the Nationa...

Cannabis users may need more anesthesia for surgery

Apr 15, 2019

By Lisa Rapaport (Reuters Health) - People who regularly use cannabis may need more than twice the usual dose of anesthesia for surgery, a U.S. study suggests. ...

In Pregnancy, Buprenorphine Use Up, Methadone Use Down

Apr 12, 2019

FRIDAY, April 12, 2019 (HealthDay News) -- From 2009 to 2015, the prevalence of methadone use decreased and buprenorphine use increased among Medicaid-enrolled pregnant women with opioid use disorder,...

CDC Clarifies Guideline on Opioid Prescribing for Chronic Pain

Apr 12, 2019

FRIDAY, April 12, 2019 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention has clarified that the new guideline on prescribing opioids for chronic pain is not meant to limit access...

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

Apr 11, 2019

(This April 10 story refiles to fix scrambled syntax in paragraph five) By Justin George Varghese and Martinne Geller (Reuters) - British drugmaker Indivior...

Peripheral Nerve Block May Cut Opioid Use After Amputation

Apr 10, 2019

WEDNESDAY, April 10, 2019 (HealthDay News) -- Peripheral nerve blockade with regular local anesthetic and liposomal bupivacaine is associated with lower oral morphine equivalent (OME) use at 72 hours ...

FDA: Patients Should Not Abruptly Stop Taking a Prescribed Opioid

Apr 10, 2019

WEDNESDAY, April 10, 2019 (HealthDay News) -- Because of the danger of "serious harm" to patients, the U.S. Food and Drug Administration is advising doctors not to suddenly stop patients from taking o...

Physical Medicine & Rehabilitation: The Unknown Specialty

Apr 09, 2019

As a family physician in private practice, our Editor in Chief, Linda Girgis, MD, understands what it means to practice in a vast area of medicine. While physicians will always juggle the challenges o...

Exclusive: Pain-care specialist agrees to testify against Purdue, other drug makers - court documents

Apr 07, 2019

By Lisa Girion and Maria Caspani (Reuters) - A physician ally of Purdue Pharma LP whose views helped drive the explosive growth in the use of addictive pain relievers for ...

Oklahoma drops several claims in opioid case against J&J, Teva

Apr 04, 2019

By Nate Raymond (Reuters) - Oklahoma's attorney general on Thursday had dropped all but a single claim against Johnson & Johnson and Teva Pharmaceutical Industries Ltd...

Novartis, Amgen in dispute over migraine drug partnership

Apr 04, 2019

By Jonathan Stempel and Deena Beasley NEW YORK/LOS ANGELES (Reuters) - Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of t...

Drug company founder, execs exploited patients to sell opioid: U.S. prosecutor

Apr 04, 2019

By Nate Raymond BOSTON (Reuters) - The founder of Insys Therapeutics Inc put profits over patient safety by bribing doctors to prescribe an addictive fentanyl spray, fueli...

Purdue's Sackler family fights 'inflammatory' Massachusetts opioid case

Apr 02, 2019

By Nate Raymond BOSTON (Reuters) - Members of the Sackler family behind OxyContin maker Purdue Pharma LP have asked a judge to toss a lawsuit by the Massachusetts attorney...

Opioid addiction diagnosis and treatment climbs with Medicaid expansion

Apr 02, 2019

By Lisa Rapaport (Reuters Health) - More low-income people addicted to opioids are getting diagnosed and treated with effective medication as a result of the Affordable Care Act, a new study sugges...

Spinal manipulation can help ease low back pain

Apr 02, 2019

By Lisa Rapaport (Reuters Health) - - Spinal manipulation therapy isn't routinely recommended as the initial treatment for low back pain, but a research review suggests th...

U.S. welcomes China's expanded clampdown on fentanyl

Apr 02, 2019

(In the third paragraph of the April 1 story, corrects to U.S. Drug Enforcement Administration from U.S. Drug Enforcement Agency) By Michael Martina BEIJING...

SUBSPECIALTIES

Advertisement